SCHEMBL8360748

SCHEMBL8360748

CCC(C)c1cn(C)c2ccc(F)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 1/20 0.50
DRD2 P14416 2/20 0.47
SLC6A4 P31645 2/20 0.47
MTNR1A P48039 3/20 0.45
MTNR1B P49286 3/20 0.45
KCNH2 Q12809 4/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP19A1 P11511 2/20 0.40
PDK1 Q15118 1/20 0.38
ICMT O60725 1/20 0.36
IDO1 P14902 1/20 0.36
AURKA O14965 1/20 0.36
JAK2 O60674 1/20 0.36
PAK4 O96013 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21661970 0.85 KDM4E (0.54) KDM4EALDH1A1DRD2SLC6A4MTNR1A
SCHEMBL18541949 0.80 BRD4 (0.49) KDM4EALDH1A1
SCHEMBL7828711 0.80 KDM4E (0.51) KDM4EALDH1A1DRD2SLC6A4MTNR1A
SCHEMBL18508879 0.78 KDM4E (0.58) KDM4EALDH1A1DRD2SLC6A4KCNH2
SCHEMBL15944077 0.77 KDM4E (0.50) KDM4EALDH1A1DRD2SLC6A4MEN1
SCHEMBL12534047 0.76 IDO1 (0.60) KDM4EALDH1A1MEN1NPC1POLB
SCHEMBL28346754 0.76 IDO1 (0.60) KDM4EALDH1A1MEN1NPC1POLB
SCHEMBL623472 0.75 HTR2C (0.51) KDM4EALDH1A1DRD2SLC6A4MEN1
SCHEMBL30520734 0.75 HTR2C (0.51) KDM4EALDH1A1DRD2SLC6A4MEN1
SCHEMBL27489308 0.75 KDM4E (0.55) KDM4EALDH1A1DRD2SLC6A4MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828325-B2 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression SOLVAY PHARMACEUTICALS B.V. (CH) 2004-12-07 US disclosed